Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.510 | Therapeutic | phenotype | RGD | Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo. | 17293494 | 2007 | ||||
|
0.510 | Biomarker | phenotype | LHGDN | Renovascular hypertension due to antithrombin deficiency in childhood. | 15338392 | 2004 | ||||
|
0.510 | Biomarker | phenotype | CTD_human | Deep vein thrombosis during enoxaparin prophylactic treatment in a young pregnant woman homozygous for factor V Leiden and heterozygous for the G127-->a mutation in the thrombomodulin gene. | 11132655 | 2000 | ||||
|
0.510 | Therapeutic | phenotype | CTD_human | Deep vein thrombosis during enoxaparin prophylactic treatment in a young pregnant woman homozygous for factor V Leiden and heterozygous for the G127-->a mutation in the thrombomodulin gene. | 11132655 | 2000 | ||||
|
0.510 | Therapeutic | phenotype | CTD_human | [Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test]. | 8967151 | 1996 | ||||
|
0.510 | Biomarker | phenotype | CTD_human | [Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test]. | 8967151 | 1996 | ||||
|
0.510 | Biomarker | phenotype | CTD_human | Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome. | 2133253 | 1990 | ||||
|
0.510 | Therapeutic | phenotype | CTD_human | Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome. | 2133253 | 1990 | ||||
|
0.510 | Biomarker | phenotype | CTD_human | Estrogen treatment of tall girls: risk of thrombosis? | 6889048 | 1983 | ||||
|
0.510 | Therapeutic | phenotype | CTD_human | Estrogen treatment of tall girls: risk of thrombosis? | 6889048 | 1983 |